Franchi Jean M. — SEC Form 4 filings
SEC reporting owner CIK 1653053. 14 Form 4 filings on record with FilingPulse; latest filed 2026-04-15.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-15 to 2026-04-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 7 filings — 27,333 shares, $1,715,449 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 6,257 shares @ $69.24 ($433,234) in Disc Medicine, Inc., filed 2026-04-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | Chief Financial Officer | 10 | — | 10 legs · 27,333 sh · $1,715,449 | 6 |
| BIODESIX INC (BDSX) | Director | 4 | — | — | 8 |
Form 4 filings — Franchi Jean M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-15 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 400 @ $69 · Sale (S): 6,257 @ $69.24 | EDGAR |
| 2026-02-27 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 353 @ $69.06 | EDGAR |
| 2026-02-19 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 4,075 @ $62.86 · Sale (S): 3,397 @ $65.01 · Sale (S): 3,684 @ $65.89 | EDGAR |
| 2026-02-11 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 19,000 @ $0 · Grant/award (A): 25,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 8,164 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 2,031 @ $59 | EDGAR |
| 2025-07-14 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 2,000 @ $57.50 | EDGAR |
| 2025-06-18 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 2,000 @ $52.26 | EDGAR |
| 2025-05-22 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 92,429 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 26,368 · Option exercise (M): 26,368 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 3,136 @ $54.58 | EDGAR |
| 2025-02-12 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 36,000 @ $0 · Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 60,766 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 36,666 @ $0 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1653053 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →